Clinical Trial Update: The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of ruxolitinib cream in adults with atopic dermatitis and sleep disturbance; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Opzelura (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis | Phase 4 | Status: TERMINATED | Results posted: 2025-12-19